FRANCA, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 3.242
EU - Europa 1.855
AS - Asia 493
AF - Africa 26
SA - Sud America 19
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.648
Nazione #
US - Stati Uniti d'America 3.223
PL - Polonia 601
IT - Italia 402
SE - Svezia 260
UA - Ucraina 186
CN - Cina 181
HK - Hong Kong 123
FI - Finlandia 79
DE - Germania 58
TR - Turchia 55
IE - Irlanda 49
SG - Singapore 49
BG - Bulgaria 47
GB - Regno Unito 37
FR - Francia 36
BE - Belgio 21
IN - India 21
CH - Svizzera 15
RU - Federazione Russa 15
SN - Senegal 15
JP - Giappone 14
CA - Canada 13
BR - Brasile 12
KR - Corea 11
AU - Australia 10
ES - Italia 10
NL - Olanda 9
VN - Vietnam 8
PK - Pakistan 7
SI - Slovenia 6
DK - Danimarca 5
NO - Norvegia 5
EG - Egitto 4
PR - Porto Rico 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CL - Cile 3
CZ - Repubblica Ceca 3
IR - Iran 3
MY - Malesia 3
TH - Thailandia 3
TN - Tunisia 3
CR - Costa Rica 2
EU - Europa 2
ID - Indonesia 2
IQ - Iraq 2
JO - Giordania 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AT - Austria 1
BD - Bangladesh 1
EE - Estonia 1
KW - Kuwait 1
KZ - Kazakistan 1
LS - Lesotho 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
Totale 5.648
Città #
Warsaw 598
Woodbridge 397
Fairfield 378
Ann Arbor 368
Chandler 331
Ashburn 256
Houston 222
Wilmington 196
Trieste 180
Jacksonville 170
Seattle 164
Cambridge 139
Hong Kong 120
Princeton 87
Dublin 49
Izmir 47
Sofia 47
Beijing 40
Dearborn 31
Boardman 24
Bremen 23
Helsinki 23
Singapore 23
Brussels 21
Falls Church 16
Fano 16
Dakar 15
Hefei 13
San Diego 13
Des Moines 12
Los Angeles 12
Bern 11
Milan 11
Redwood City 10
Rome 10
Shanghai 9
Dong Ket 8
Nanjing 8
Seoul 8
Guangzhou 7
Kocaeli 7
New York 7
Phoenix 7
Tokyo 7
Washington 7
Kunming 6
Buffalo 5
Fremont 5
Fuzhou 5
Hebei 5
Jinan 5
Munich 5
Pignone 5
Pune 5
Sydney 5
Venice 5
Verona 5
Amsterdam 4
Bayamón 4
Bielefeld 4
Changsha 4
Chicago 4
Guangdong 4
Guelph 4
Huesca 4
London 4
Nashville 4
Oslo 4
São Paulo 4
Taiyuan 4
Al Mansurah 3
Atlanta 3
Boulder 3
Brno 3
Chengdu 3
Chennai 3
Dallas 3
Denver 3
Detroit 3
Düsseldorf 3
Frankfurt am Main 3
Geneva 3
Ljubljana 3
Madrid 3
Manchester 3
Montreal 3
Mumbai 3
Norwalk 3
Paris 3
Redmond 3
Shenyang 3
Sidi Bou Saïd 3
Toronto 3
Udine 3
Ardmore 2
Arnhem 2
Aveiro 2
Bangkok 2
Bengaluru 2
Bologna 2
Totale 4.345
Nome #
Pharmacogenetics of thiopurines 365
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 356
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 343
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 248
Pharmacogenetics of treatments for inflammatory bowel disease 190
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 169
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 167
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 167
Personalized therapies in pediatric inflammatory and autoimmune diseases. 163
Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. 151
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 151
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype 147
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 145
Glutathione S-Transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. 140
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. 136
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 136
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 136
Human Immunodeficiency Virus (HIV-1) Auxiliary Protein Vif and Cellular APOBEC Deaminases: Their Roles Unveiled? 135
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 134
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 133
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 133
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 132
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 127
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 126
Expression of kidney and liver bilitranslocase in response to acute biliary obstruction. 117
The ectopic F(O)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1. 110
DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. 105
Heterodimeric amino acid transporter glycoprotein domains determining functional subunit association 103
Human DEAD-box ATPase DDX3 shows a relaxed nucleoside substrate specificity 99
Identification and Functional Characterization of Bilitranslocase in Sea-Bass (Dicentrarchus labrax) Hepatopancreas 96
Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia 92
Processes for incorporation of pharmacogenetic tests and interpretations in medical records for clinical practice. 88
ITPA genetic polymorphism is possibly associated with survival rate in Korean children with acute lymphoblastic leukemia. 84
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 84
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 74
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 70
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 65
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism 63
SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation 62
Pharmacogenetics of glucocorticoid response 60
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 60
Biomarkers for gastrointestinal adverse events related to thiopurine therapy 48
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 46
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 35
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 33
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 25
Impact of mercaptopurine metabolites on disease outcome in the AIEOP-BFM 2009 protocol for acute lymphoblastic leukemia 9
null 3
Totale 5.861
Categoria #
all - tutte 14.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019282 0 0 0 0 0 0 0 0 0 0 183 99
2019/20201.332 85 61 64 232 93 145 184 154 102 67 75 70
2020/2021867 74 69 74 84 106 80 80 60 52 89 38 61
2021/2022577 32 38 28 31 24 51 46 28 68 61 40 130
2022/20231.008 96 155 62 145 96 160 8 94 108 30 46 8
2023/2024628 34 54 32 46 67 48 116 117 8 28 78 0
Totale 5.861